NCT00538148View on ClinicalTrials.gov

Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD

PHASE4CompletedINTERVENTIONAL

Enrollment

668

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

September 30, 2004

Study Completion Date

September 30, 2004

Conditions

Bronchitis, Chronic

Interventions

DRUG

Telithromycin

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY

NCT00538148 - Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD | Biotech Hunter | Biotech Hunter